Compass Financial Management’s Immix Biopharma IMMX Stock Holding History
Bought
Maintained
Sold
Other funds holding IMMX
SVCM
OM
Compass Financial Management's IMMX Position: Q3 2026 in Review
Compass Financial Management held its Immix Biopharma (IMMX) position steady in Q3 2026 at 6,000 shares worth $62.4K. The position accounts for 0.01% of the portfolio, ranked #693.
Compass Financial Management first reported a position in IMMX in Q2 2026 and has held it in 2 quarters since. 136 funds tracked by Wall St. Rank hold IMMX as of Q3 2026.
- Compass Financial Management held 6,000 shares of Immix Biopharma worth $62.4K as of Q3 2026.
- Compass Financial Management left its Immix Biopharma share count unchanged in Q3 2026.
- Immix Biopharma made up 0.01% of Compass Financial Management's portfolio in Q3 2026, its #693 holding.
- Compass Financial Management first reported a position in Immix Biopharma in Q2 2026 and has held it in 2 quarters since.
- 136 funds tracked by Wall St. Rank held Immix Biopharma as of Q3 2026.
Based on Compass Financial Management's 13F filing for Q3 2026, filed 30 Oct 2026.